Login
← Go Back
JFL Life Sciences
JFLLIFE · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 14, 2025
Stock Price vs Company Growth
1d
4.6%
1w
1.0%
1m
1.0%
3m
1.4%
6m
13.1%
1y
16.5%
all
20.4%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 10.3 4.6%
9.65
14.4
Company Overview
Sales
131 Cr
Growth: 86.3%
Profit after Tax
6.77 Cr
Growth: 5.7%
Micro Cap
34.2 Cr
P/E: 5.0x
Industry P/E: 32.5x
Fundamentals
Sales (Cr) ₹ 131
Growth 86.3%
EBITDA 9.1%
P/S 0.3x
Dividend 0.0%
P/E 5.0x
Book Value ₹ 14.2
PEG Ratio 0.1x
ROE 15.1%
P/B 0.8x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
JFL Life Sciences manufactures a wide range of pharmaceutical formulations. The company’s major products types are Dry powder injections; Tablets & Capsules (B-Lactam) solid oral dosage form; Tablet and capsules (General); and Oral Rehydration Solutions (ORS). Major Events and Milestones2010: The company was incorporated as a private limited company under the name JFL Life Sciences Private Limited.
Belongs to (1 Indices)